Leveraging Induced Pluripotent Stems Cell Technology, Researchers Control Diabetes in Mice
“The generation of glucose-responsive islet-like organoids that are able to avoid immune detection provides a promising alternative to cadaveric and device-dependent therapies in the treatment of diabetes.” Evans further suggested, “We now have a product that could potentially be used in patients without requiring any kind of device.”
